Mevastatin |
compactin |
73573-88-3 |
ML-236B |
Mevastatina |
Mevastatine |
Mevastatinum |
Mevastatinum INN-Latin |
Antibiotic ML 236B |
CS 500 |
UNII-1UQM1K0W9X |
ML 236 B |
1UQM1K0W9X |
CHEMBL54440 |
(1S,7S,8S,8aR)-8-2-(2R,4R)-4-hydroxy-6-oxooxan-2-ylethyl-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate |
CHEBI:34848 |
MFCD05662341 |
ML236B |
Mevastatin INN |
Compactin (penicillium) |
Mevastatine INN-French |
Mevastatina INN-Spanish |
(S)-((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate |
Butanoic acid, 2-methyl-, (1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-2-(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-ylethyl-1-naphthalenyl ester, (2S)- |
SMR000336944 |
CCRIS 4505 |
kompaktin |
NCGC00095942-01 |
Mevastatin- Bio-X |
EC 700-442-0 |
SCHEMBL1116 |
DSSTox_CID_20684 |
DSSTox_RID_79540 |
DSSTox_GSID_40684 |
Lopac0_000754 |
MLS000721804 |
MLS000759452 |
MLS001424284 |
MLS002207227 |
GTPL3031 |
DTXSID4040684 |
Mevastatin, >=96% (HPLC) |
HMS2052P07 |
HMS2089D10 |
HMS2232N09 |
HMS3262G10 |
HMS3268A19 |
HMS3412H15 |
HMS3676H15 |
HMS3713B06 |
ZINC3833876 |
Tox21_111540 |
Tox21_500754 |
BDBM50011036 |
CS-500 |
NSC779705 |
s4223 |
AKOS015994712 |
Mevastatin, >=95% (HPLC), powder |
CCG-101174 |
CS-1234 |
DB06693 |
KS-1085 |
LP00754 |
NC00424 |
NSC 759322 |
NSC-779705 |
SDCCGSBI-0050732.P002 |
7-(1,2,6,7,8,8a-Hexahydro-2-methyl-8-(2-methylbutyryloxy)naphthyl)-3-hydroxyheptan-5-olide |
SMP1_000077 |
NCGC00025202-04 |
NCGC00261439-01 |
(1S,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl(2S)-2-methylbutanoate |
BM164666 |
Butanoic acid, 2-methyl-, (1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)- |
Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-7-methyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha(R*),7-beta,8-beta(2S*,4S*),8a-beta))- |
HY-17408 |
I518 |
Mevastatin 100 microg/mL in Acetonitrile |
AB0013739 |
CAS-73573-88-3 |
B1788 |
EU-0100754 |
M2275 |
H11997 |
M 2537 |
AB00588266-06 |
AB00588266-08 |
AB00588266_09 |
573M883 |
A837861 |
Q414407 |
SR-01000729493 |
L-637312 |
SR-01000729493-4 |
BRD-K94441233-001-03-1 |
BRD-K94441233-001-17-1 |
(1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate |
(1S,7S,8S,8aR)-8-{2-(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-ylethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate |
(S)-((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate |
(S)-2-Methyl-butyric acid (1S,7S,8S,8aR)-8-2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester |
2-Methyl-butyric acid 8-2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester |
2-Methyl-butyric acid 8-2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester((+)-compactin) |
2-Methyl-butyric acid 8-2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester(compactin) |